✦ LIBER ✦

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

✍ Scribed by Margaret Deutsch; Jeffrey Crawford; Kenneth Leopold; Walter Wolfe; William Foster; James Herndon; Susan Blackwell; Rebecca Yost

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 939 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940815)74:4<1243::aid-cncr2820740411>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical stage II non-small cell lung ca

Clinical stage II non-small cell lung cancer treated with radiation therapy alone:The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)

✍ Seth A. Rosenthal; Walter J. Curran Jr.; Scoff H. Herbert; Edward N. Hughes; How 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Background. The prognosis of patients with clinically staged hilar nodal involvement (Stage N1) or clinical Stage I1 non-small cell lung cancer (NSCLC, Stage T1-2NlMO) treated with radiation therapy (RT) alone is not well established. Methods. Records of 758 patients with clinical Stage 1-111 NSCLC

Clinical patterns and treatment outcome

Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer

✍ Tatsuro Okamoto; Riichiroh Maruyama; Fumihiro Shoji; Jiro Ikeda; Tetsuya Miyamot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

A phase II study of methotrexate, doxoru

A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer

✍ Gianfranco Buccheri; D. Ferrigno; A. Rosso 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 826 KB

Combination chemotherapy with mitomycin

Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer

✍ Harvey B. Niell; John P. Griffin; William H. West; Charles L. Neely 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Long term results of a phase I/II study

Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer

✍ James A. Bonner; Robert T. Eagan; Vichaivood Liengswangwong; Stephen Frytak; Edw 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Background. A Phase 1/11 study of an aggressive sixdrug chemotherapy regimen followed by the use of sequential hemibody radiation therapy as a possible noncross-resistant systemic treatment was undertaken for patients with extensive stage small cell lung cancer. Methods. The 20 enrolled patients re